Page last updated: 2024-12-05
cyanophos
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 17522 |
| CHEMBL ID | 2271089 |
| CHEBI ID | 38621 |
| SCHEMBL ID | 83422 |
| MeSH ID | M0057733 |
Synonyms (61)
| Synonym |
|---|
| cyanophos |
| phosphorothioic acid, o-(4-cyanophenyl) o,o-dimethyl ester |
| o-4-cyanophenyl o o-dimethyl phosphorothioate |
| ciafos |
| o,o-dimethyl o-(4-cyanophenyl) thionophosphate |
| CHEBI:38621 , |
| o-p-cyanophenyl o,o-dimethyl phosphorothioate |
| o,o-dimethyl-o-p-cyanophenyl phosphorothioate |
| 2636-26-2 |
| 4-(dimethoxyphosphinothioyloxy)benzonitrile |
| o-(4-cyanophenyl) o,o-dimethyl phosphorothioate |
| o-(4-cyanophenyl) o,o-dimethyl thiophosphate |
| oms 869 |
| bayer 34727 |
| phosphorothioic acid, o,o-dimethyl ester, o-ester with p-hydroxybenzonitrile |
| cyanophos [bsi:iso] |
| einecs 220-130-3 |
| cyap |
| oms 226 |
| cyanox |
| o,o-dimethyl-o-(4-cyano-phenyl)-monothiophosphat [german] |
| o,o-dimethyl o-4-cyanophenyl thiophosphate |
| bay 34727 |
| o,o-dimethyl o-4-cyanophenyl phosphorothioate |
| brn 2695901 |
| o,o-dimethyl phosphorothioate o-ester with p-hydroxybenzonitrile |
| may & baker s-4084 |
| ent 25,675 |
| epa pesticide chemical code 268200 |
| cynock |
| s 4084 |
| ai3-25675 |
| caswell no. 268a |
| (o-p-cyanophenyl-o,o-dimethylphosphorothioate) |
| hsdb 6427 |
| sumitomo s 4084 |
| o-4-cyanophenyl o,o-dimethyl phosphorothioate |
| 4-dimethoxyphosphinothioyloxybenzonitrile |
| C18397 |
| unii-2ab0z99oxp |
| o,o-dimethyl-o-(4-cyano-phenyl)-monothiophosphat |
| 2ab0z99oxp , |
| FT-0603169 |
| AKOS015888321 |
| SCHEMBL83422 |
| S-4084 , |
| CHEMBL2271089 |
| phosphorothioic acid o-(4-cyanophenyl) o,o-dimethyl ester |
| cyanophos [mi] |
| cyanophos [iso] |
| cyanophos [hsdb] |
| bay-34727 |
| phosphorothioic acid o,o-dimethyl ester, o-ester with p-hydroxybenzonitrile |
| o,o-dimethyl-o-(4-cyano-phenyl)-monothiophosphate |
| o,o-dimethyl o-(p-cyanophenyl) phosphorothioate |
| o-(4-cyanophenyl) o,o-dimethyl thiophosphate # |
| DTXSID0041806 |
| cyanophos, pestanal(r), analytical standard |
| J-016395 |
| Q1147014 |
| cyanophos 10 microg/ml in isooctane |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " 14C-recoveries (expressed as % relative to the dosed 14C) in faeces and urine were 2-3 and 95-96% respectively for the low-dose and 13-14 and 86% respectively for the high-dose." | ( Metabolism of Cyanox in the rat. I. Absorption, disposition, excretion and biotransformation. Kaneko, H; Nakatsuka, I; Onogi, M; Saito, K; Shiba, K; Tomigahara, Y; Yamada, H, 1995) | 0.29 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Roles (2)
| Role | Description |
|---|---|
| agrochemical | An agrochemical is a substance that is used in agriculture or horticulture. |
| EC 3.1.1.7 (acetylcholinesterase) inhibitor | An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Drug Classes (2)
| Class | Description |
|---|---|
| organothiophosphate insecticide | |
| organic thiophosphate | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 27.78
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.78) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||